Media Outlet: Targeted Oncology
4/11/2024- A global phase 3 clinical trial planning to evaluate an mRNA vaccine for the treatment of patients with high-risk melanoma that have already undergone surgery is underway. Jeff Yorio, M.D., medical oncologist and central Texas research leader for Texas Oncology, discussed with Targeted Oncology the unmet needs in this patient group and plans for this phase 3 study.
Media Outlet: KTBC-TV (FOX, Austin)
4/2/2024- Jeff Yorio, M.D., lead trial investigator at Texas Oncology-Austin Central joined KTBC-TV’s (FOX, Austin) “HealthBeat” segment to discuss the new clinical trial using mRNA technology to prevent melanoma reoccurrence. Dr. Yorio shared more about the status of patient enrollment, why this clinical trial is so unique, and the likelihood of this vaccine going to market within the next few years.
Media Outlet: Austin Medical Times, Houston Medical Times
4/2/2024- While the prospect of cancer recurrence may evoke feelings of fear, anger, or uncertainty, it’s also good to remember that feelings of hope and resilience can coexist. Hope Engelbrecht, M.D., Texas Oncology–Cedar Park, Round Rock North and Abhilasha Patel, M.D., Texas Oncology–Houston Willowbrook Radiation Oncology, explain that understanding the nature of recurrence, addressing the emotional and practical concerns to cope with the diagnosis, and actively engaging in treatment decisions, one can navigate the journey of cancer recurrence with support, strength, and perseverance.
Media Outlet: Austin American-Statesman
3/25/2024- Texas Oncology has enrolled patients in an innovative stage 3 clinical trial testing an mRNA vaccine for melanoma treatment. Jeff Yorio, M.D., Texas Oncology-Austin Central, shared how the melanoma vaccine is created, what results are expected and what the trial could mean for the future of melanoma treatment.
Media Outlet: KTBC-TV (FOX, Austin)
3/23/2024- Heather King, M.D., FACS, Texas Breast Specialists-Austin Lakeway and West 37th Street joined KTBC-TV’s (FOX, Austin) “HealthBeat” segment to discuss the Breast Cancer Risk Assessment Tool, given Oliva Munn’s recent diagnosis. Dr. King shared with viewers the different statistical models to test for breast cancer risk, the gold standard of screening, how mammograms are the roadmap to the breast and explained what Luminal B cancer is.
Media Outlet: KTBC-TV (FOX, Austin)
3/20/2024- Thiru V. Lakshman, M.D., FACS, FASCRS, Texas Colon & Rectal Specialists-Austin Central and Austin North, joined KTBC-TV's (FOX, Austin) Rebecca Thomas to talk about risks and prevention this Colorectal Cancer Awareness Month.
Media Outlet: The American Journal of Managed Care
3/12/2024- The mental health struggle that accompanies a cancer diagnosis is real, and the burden of dealing with so many conflicting emotions falls not only on the patients but also on their caregivers, families, friends, and physicians. Kathryn E. Hudson, M.D., director of survivorship and medical oncologist at Texas Oncology-Austin Central explains the complex picture of emotions patients feel throughout their cancer journey and why mental health support should be a part of all cancer care.
Media Outlet: Austin Medical Times, Houston Medical Times
3/1/2024- Scans are an essential part of cancer treatment and survivorship care, so recognizing and managing scanxiety is essential to help patients get the care they need. Shaun P. McKenzie, M.D., FACS, Texas Oncology Surgical Specialists–Round Rock and South Austin and Antonio Nathan Villamor III, M.D., colorectal surgeon, Texas Colon & Rectal Specialists–Pasadena, explain that while colonoscopies often have a reputation for being stressful, painful, or embarrassing, this common procedure is usually quick and can be done under different types of anesthesia.
Media Outlet: KTBC-TV (FOX, Austin)
2/8/2024- Rebecca L. Wiatrek, M.D., FACS, Texas Oncology Surgical Specialists-Austin Central and Round Rock joined KTBC-TV’s (FOX, Austin) “HealthBeat” segment to discuss stomach cancer, in light of country singer Toby Keith’s recent death by this disease. According to the American Cancer Society, stomach cancer accounts for 1.5% of all new cancer cases diagnosed each year in the U.S., making this disease fairly rare, yet one to know the signs and symptoms for.
Media Outlet: Austin Medical Times, Houston Medical Times
2/2/2024- When it comes to the heart and cancer treatment, balancing the effectiveness of cancer therapies with the preservation of heart function is essential to improving the long-term cardiovascular health of cancer patients. Karen Cohen, M.D.,Texas Oncology–Austin Central and Round Rock and Andrew Jackson, M.D., Texas Oncology–The Woodlands, share how healthcare providers and cancer patients can make informed decisions when it comes to matters of the heart.